Salt Composition
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Acne
Customers also bought
More About Isograce 30mg Tablet
Benefits
In Treatment of Acne Isograce 30mg Tablet helps treat acne by reducing the production of sebum (a natural substance) that causes acne. This kills acne-causing bacteria and prevents spots or pimples from appearing. It usually takes a few weeks to have a noticeable effect so keep taking it even if it appears not to be working. Sometimes acne may get worse before it gets better, however, with proper use, your skin will get clearer. This medicine will help improve your mood and uplift your confidence as your skin becomes acne-free.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Isograce 30mg Tablet is to be taken with food.
How it works
Isograce 30mg Tablet is a derivative of vitamin A. It acts on glands (sebaceous) to reduce the production of a natural substance (sebum) that causes acne. Also, the controlled sebum production kills acne-causing bacteria. It also works as an anti-inflammatory to decrease inflammation (redness and swelling).
Caution: It is important to consult your doctor regarding alcohol consumption while taking Isograce 30mg Tablet .
Not Safe: Isograce 30mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Seek medical advice from your doctor: Isograce 30mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Isograce 30mg Tablet may cause side effects which could affect your ability to drive. Your night vision may get worse during your treatment. This can happen suddenly. Drowsiness and dizziness have been reported very rarely. This may affect your driving ability.
Safe when prescribed by an expert: Isograce 30mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Isograce 30mg Tablet may not be needed in these patients. Doctor consultation is advised. If you experience excessive tiredness, puffy eyes and difficulty in urination while taking this medicine, inform your doctor and stop the therapy.
Not Safe: Isograce 30mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Doctor consultation is advised.
What if I forget to take it?
If a dose of Isograce 30mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
C-23/107 A,KRISHNA INDUSTRIAL ESTATE, NR. ANUP TECH,OPP.BIDC GORWA,VADODARA-16(GUJARAT).
References
Robertson DB, Maibach HI. Dermatologic Pharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1056
Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1812
Sardana K, Madan A. How to Treat Acne. Sardana K, editor. In: Clinical Approach to Acne Vulgaris. 1st ed. New Delhi: CBS Publishers & Distributors Pvt. Ltd.; 2015. pp. 64-67
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 745-47
Isotretinoin. Nutley, New Jersey: Roche Laboratories Inc.; 2002 (on 2 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (03 Apr. 2019)
Central Drugs Standard Control Organization. Safety guidelines for isotretinoin. 2018 (05 Jul. 2023)
CiplaMed. Isotretinoin (05 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
